Cellular vulnerability in brain aging and Alzheimer's disease - Clinical correlates and molecular background

被引:0
|
作者
Giannakopoulos, P
Gold, G
Michel, JP
Bouras, C
机构
[1] Univ Geneva, Sch Med, Dept Psychiat, HUG Belle Idee, CH-1225 Geneva, Switzerland
[2] Univ Geneva, Sch Med, Dept Geriatr, HUG Belle Idee, CH-1225 Geneva, Switzerland
来源
ANNALES DE MEDECINE INTERNE | 1998年 / 149卷 / 04期
关键词
Alzheimer; brain aging; centenarians; neuropathology;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The neuropathological changes associated with normal brain aging and Alzheimer's disease involve specific cortical circuits. Extensive hippocampal alterations are correlated with age-associated memory impairment, while substantial neurofibriliary tangle formation in neocortical association areas of the temporal lobe is a prerequisite for the development of Alzheimer's disease. Several lines of evidence indicate that there is no correlation between senile plaque densities and the degree of dementia in this disorder. The cortical involvement in the ninth and tenth decades of life is different from that observed in younger patients in that parietal and cingulate areas are affected early in the course of Alzheimer's disease, and neocortical senile plaques densities are strongly correlated with the severity of dementia. Moreover, Alzheimer's disease pathology is characterized in these very old patients by high neurofibrillary tangle densities in the anterior CA1 field, but not in the entorhinal cortex and inferior temporal cortex. These patterns of lesion distribution are discussed in respect to the neurochemical, genetic and metabolic factors which may influence the neuronal vulnerability in Alzheimer's disease.
引用
收藏
页码:187 / 191
页数:5
相关论文
共 50 条
  • [21] Alzheimer's disease : cellular and molecular aspects
    Octave, Jean-Noel
    Pierrot, Nathalie
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2008, 192 (02): : 323 - 332
  • [22] Brain imaging correlates of apathy in Alzheimer's disease
    Benoit, N
    Robert, PH
    Koulibaly, PM
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 91 - 91
  • [23] Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer's disease
    Phillips, Jared M.
    Winfree, Rebecca L.
    Seto, Mabel
    Schneider, Julie A.
    Bennett, David A.
    Dumitrescu, Logan C.
    Hohman, Timothy J.
    ACTA NEUROPATHOLOGICA, 2024, 148 (01)
  • [24] Brain fuel metabolism, aging, and Alzheimer's disease
    Cunnane, Stephen
    Nugent, Scott
    Roy, Maggie
    Courchesne-Loyer, Alexandre
    Croteau, Etienne
    Tremblay, Sebastien
    Castellano, Alex
    Pifferi, Fabien
    Bocti, Christian
    Paquet, Nancy
    Begdouri, Hadi
    Bentourkia, M'hamed
    Turcotte, Eric
    Allard, Michele
    Barberger-Gateau, Pascale
    Fulop, Tamas
    Rapoport, Stanley I.
    NUTRITION, 2011, 27 (01) : 3 - 20
  • [25] ADAR Dysfunction in Brain Aging and Alzheimer's Disease
    McEntee, Cali M.
    Cavalier, Alyssa N.
    LaRocca, Thomas J.
    FASEB JOURNAL, 2022, 36
  • [26] The role of estrogen in brain aging and Alzheimer's disease
    Birge, SJ
    WOMEN'S HEALTH AND MENOPAUSE: RISK REDUCTION STRATEGIES - IMPROVED QUALITY OF HEALTH, 1999, 13 : 145 - 149
  • [27] Homeostatic Disinhibition in the Aging Brain and Alzheimer's Disease
    Gleichmann, Marc
    Chow, Vivian W.
    Mattson, Mark P.
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 24 (01) : 15 - 24
  • [28] Humoral immunity in brain aging and Alzheimer's disease
    Bouras, C
    Riederer, BM
    Kövari, E
    Hof, PR
    Giannakopoulos, P
    BRAIN RESEARCH REVIEWS, 2005, 48 (03) : 477 - 487
  • [29] Decreased pH in the aging brain and Alzheimer's disease
    Decker, Yann
    Nemeth, Eszter
    Schomburg, Robert
    Chemla, Axel
    Fulop, Livia
    Menger, Michael D.
    Liu, Yang
    Fassbender, Klaus
    NEUROBIOLOGY OF AGING, 2021, 101 : 40 - 49
  • [30] Calcium regulation in brain aging and Alzheimer's disease
    不详
    PHARMACOLOGICAL REPORTS, 2005, 57 (03) : 424 - 424